Editoral: ICRF 159.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001808:Blood Vessels / Q000187:drug effects / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009360:Neoplastic Cells, Circulating; D012516:Osteosarcoma / Q000188:drug therapy; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D010879:Piperazines